S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7119 +0.14%
AFTER HRS · 18:25 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

AMGN

AMGEN INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
437.17
−1.77 −0.40%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $236.3BP/E 27.2DIV YIELD 1.70%FCF YIELD 4.31%REV TTM $38.1B +9.1%NET INCOME $8.7B +32.1%NET DEBT $43.3B52W 291.16 – 444.12SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$10.1B+9.5%72.0%$3.5B$2.4B+65.9%4.37$4B$513M$3.5BAug 5
Q1 2026 · Mar 31$8.6B+5.8%68.2%$2.7B$1.8B+5.1%3.34$2.2B$712M$1.5BAug 5
Q4 2025 · Dec 31$9.9B+8.6%69.8%$2.7B$1.3B+112.6%2.46$1.6B$642M$961MAug 5
Q3 2025 · Sep 30$9.6B+12.4%67.8%$2.5B$3.2B+13.6%5.93$4.7B$436M$4.2BFeb 13
Q2 2025 · Jun 30$9.2B+9.4%67.2%$2.7B$1.4B+92.0%2.65$2.3B$369M$1.9BAug 5
Q1 2025 · Mar 31$8.1B+9.4%63.6%$1.2B$1.7B—3.20$1.4B$411M$980MMay 1
Q4 2024 · Dec 31$9.1B+10.9%65.7%$2.3B$627M−18.3%1.16$4.8B$371M$4.4BFeb 13
Q3 2024 · Sep 30$8.5B+23.2%61.1%$2B$2.8B+63.6%5.22$3.6B$257M$3.3BFeb 13
Q2 2024 · Jun 30$8.4B—61.4%$1.9B$746M—1.38$2.5B$238M$2.2BFeb 13
Q1 2024 · Mar 31$7.4B—57.0%$991M−$113M—-0.21$689M$230M$459MFeb 13
Q4 2023 · Dec 31$8.2B—62.0%$1.3B$767M—1.43$538M$249M$289MFeb 13
Q3 2023 · Sep 30$6.9B—73.8%$2B$1.7B—3.22$2.8B$248M$2.5BFeb 13

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$36.8B67.2%$9.1B$7.7B21.0%14.23$10B$1.9B$8.1B$0$5.1B
FY2024 · to Dec 31$33.4B61.5%$7.3B$4.1B12.2%7.56$11.5B$1.1B$10.4B$200M$4.8B
FY2023 · to Dec 31$28.2B70.0%$7.9B$6.7B23.8%12.49$8.5B$1.1B$7.4B$0$4.6B
FY2022 · to Dec 31$26.3B75.7%$9.6B$6.6B24.9%12.11$9.7B$936M$8.8B$6.4B$4.2B
FY2021 · to Dec 31$26B75.2%$7.6B$5.9B22.7%10.28$9.3B$880M$8.4B$5B$4B
FY2020 · to Dec 31$25.4B75.8%$9.1B$7.3B28.6%12.31$10.5B$608M$9.9B$3.5B$3.8B

Every number comes from AMGEN INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch AMGN. Know when insiders buy.
One email the day a filing lands. Free.